Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Friday, May 16, 2014

NeuralStem Inc. CEO, To Present At And Give Update On Trials

The company has also completed a Phase Ib trial testing its first-in-class neurogenic compound, NSI-189, in patients with major depressive disorder .

http://ift.tt/1gwsk8P

No comments:

Post a Comment

Popular Stem Cell Roundup Posts